Rotavirus is the most important worldwide cause of severe gastroenteritis. Extensive efforts have been devoted to the design of a vaccine that will prevent disease, but development of a more effective vaccine strategy may require progress in the understanding of the mucosal immune response to replicating viral antigens. In this article, we report the characterization of the intestinal antibody response of a murine model to heterologous infection with the rhesus rotavirus vaccine strain. We have adapted the enzyme-linked immunospot assay to measure this response without the difficulties associated with measurement of antibodies in intestinal contents or the artifacts associated with culturing of lymphocytes. The predominant response in terms of antibodysecreting cells (ASC) is seen in the small intestine lamina propria, which can be measured within 4 days of infection, peaks 3 weeks after infection, and remains near that level for longer than 8 weeks. The magnitude of the immunoglobulin A (IgA) cell response is approximately 10 times greater than the intestinal IgG cell response, and IgM cells are rare. Virus-specific ASC constitute approximately 50% of all ASC in the gut at the peak of the virus-specific response. This response is considerably greater than responses to nonreplicating mucosal antigens measured by similar techniques. Enteral infection engenders minimal virus-specific ASC response in the spleen. Rhesus rotavirus-specific enzyme-linked immunosorbent assay and neutralization assays of serum and intestinal contents did not correlate with virus-specific ASC response.
Rotavirus is an important cause of severe gastroenteritis in humans, as well as in other mammalian and avian species (15, 26) . In children under the age of two years, it is the single most important cause of severe diarrhea and contributes significantly to infant mortality in less developed countries (29, 56) . Although death due to rotavirus gastroenteritis occurs rarely in developed countries, it is still an extremely common cause of morbidity and physician visits (20, 21) . Rotavirus can also cause disease in adults, especially the elderly and the immunocompromised (22) . The tremendous worldwide impact of this virus has led to efforts to control this disease by the development of an effective vaccine.
The development of efficient vaccine strategies may be dependent on an understanding of the host immune response to natural infections and vaccination. Immunity to rotavirus infection has been studied with humans and several animal models, but the precise nature of the host response to infection or vaccination is still not clear. Several studies have suggested the importance of local antibodies at the mucosal surface of the small intestine as a major determinant of resistance to rotavirus illness (3, 5, 31, 39, 40, 49, 52, 55 Studies on specific antibody responses at the mucosal level have been limited by technical difficulties of immunohistochemical staining and plaque assays as well as inherent difficulties of quantitation in these assays. A modification of the enzyme-linked immunospot (ELISPOT) technique has allowed us to accurately enumerate functionally active antibody-secreting cells (ASC) within intestinal tissues and define the local antibody production in terms of specific location, kinetics, antigen specificity, and isotype. Use of this assay directly on freshly isolated lymphocytes from the gut-associated lymphoid tissues without significant in vitro manipulations allows for the most accurate estimation of their in vivo activity.
Though various animal models have been developed to study the pathogenesis of and immune response to rotavirus infection, none represents a perfect system. The short gestation period, modest price, ease of isolation of animals, commercial availability of immunological reagents, and the well-characterized immune system make the suckling mouse a convenient small-animal model which has been widely used (16, 23, (35) (36) (37) (38) 46) . Moreover, the infection in suckling mice closely parallels that seen in human infants in pathogenesis, pathological lesions, and symptomatic but selflimiting diarrheal illness. For these reasons, we chose this model for the study of intestinal immune response.
The vaccine strategy most widely tested to date utilizes animal viruses that are naturally attenuated in humans (27) .
Rhesus rotavirus (RRV), a simian strain, has been effective at stimulating only type-specific immunity in various field trials (8, 17-19, 44, 45, 67) . This rotavirus strain has previously been shown to replicate and cause disease in mice when administered at sufficient doses (43) . Because Intestinal fluid collection. The contents of the small intestine were collected by a method previously described, with minor modification (14) . Briefly, after the small intestines were removed, the outside of each was rinsed twice with cold Hanks balanced salt solution, and about 5 (12, 63 antigen for 2 h at 37°C (the optimal incubation time and cell concentrations were determined in preliminary experiments). Once the incubation was complete, the cells were washed from the membrane with PBS. Detection of bound mouse immunoglobulin was accomplished with isotype-specific biotinylated anti-mouse immunoglobulin (Kirkegaard & Perry Laboratories, Inc., Gaithersburg, Md.) and avidinhorseradish peroxidase conjugate (Vector Labs, Burlingame, Calif.) by employing the precipitating substrate 3-amino-9-ethylcarbazole (Sigma Chemical Co., St. Louis, Mo.), which resulted in red-brown spots. Figure 1 is a representative photograph of the ELISPOT assay. The spots were enumerated under x 2 to x 6 magnification with an Olympus SZ-PT zoom stereo microscope with a halogen fiberoptic light source (by the same individual). Within experiments, multiple lanes of a particular type were run, and the mean was used to determine the total number of spots per 106 viable mononuclear cells. Very high numbers of spots per lane (>300) were difficult to count because of the coalescence of spots, and the results were taken from wells incubated with fewer cells.
ELISA. IgG and IgA isotype-specific antibodies to rotavirus were measured in the serum and intestinal contents by using an indirect double-sandwich enzyme-linked immunosorbent assay (ELISA). IgM ELISA was not performed. A guinea pig anti-RRV hyperimmune serum was developed, and IgG was affinity purified from this serum by the Membrane Affinity Separation System (Nygene Corp., Yonkers, N.Y.). This IgG was used as capture antibody on Immulon II microtiter plates (Dynatech, Alexandria, Va.) to enhance the binding of cesium chloride gradient-purified rotavirus. Optimum dilution for the capture antibody and rotavirus was determined by checkerboard titration in preliminary studies to ensure adequate rotavirus binding and minimal nonspecific interactions. The plates were blocked with 2% FBS, and twofold dilutions of serum or intestinal content samples in PBS with 1% FBS were added and incubated for 2 h. Subsequently, the bound anti-rotavirus antibodies were detected by using biotinylated isotype-specific goat anti-mouse immunoglobulin and avidin-horseradish peroxidase conjugate (as above); o-phenylenediamine dihydrochloride was used as the soluble substrate (Sigma Chemical Co.) in a 0.4-mg/ml solution in citrate buffer, pH 5.3, and activated with 0.2 ,ul of 30% hydrogen peroxide per ml. The reaction was stopped after 10 min by the addition of 3 N sulfuric acid, and the A490 of the reactants was read on an EL309 automated microplate reader (Biotek, Winooski, Vt.). Parallel wells that were not coated with RRV were used as controls to quantitate nonspecific binding; control values were subtracted from those for the RRV-coated wells. All samples were run in triplicate, and titers are reported as the reciprocal of the highest dilution giving a mean absorbance reading of >0.100 optical density units.
Immunohistochemical focus neutralization assay. Serum and intestinal contents were assayed for RRV neutralization by an immunohistochemical focus neutralization assay as previously described (50) . The ASC per 106 specific ASC were seen in some experiments. This phenomenon, previously described, is believed to be secondary to the secretion of cross-reactive antibodies against a variety of antigens, which is most marked in the spleens of 1-to 5-week-old mice during the acquisition and maturation of the B-cell repertoire (28) . Hybridoma cells secreting rotavirus-specific antibodies against VP6, VP7, and VP4 (255/60, 4F8, and 7A12, respectively) were included as positive and negative controls in each experiment and consistently showed equivalent numbers of spots in the immunoglobulin and rotavirus capture lanes. Lanes coated with irrelevant antigens such as cholera toxin or no capture also showed <33 ASC per 106 specific ASC.
Cycloheximide treatment of the hybridoma cells prior to and during the incubation decreased the number of spots, indicating that the assay accurately defined active antibody secretion and did not detect membrane-bound fragments (10) . At a concentration of 100 p.g/ml, monoclonal antibody 4F8 hybridomas showed a 76% reduction in spot formation, and monoclonal antibody 7A12 hybridomas showed an 83% reduction.
Sensitivity of ELISPOT. (see Fig. 3 ), probably reflecting the immaturity of the immune system at an age of 3 weeks or less as previously described (1) . Figure 2 shows a comparison of the ASC (IgG, IgM, and IgA) in the small intestine LP tissue from mice that were enterally infected with rotavirus with similar cells from mock-infected animals. The marked rise of IgA ASC between 15 and 25 days of age (approximately 5 to 15 days postinfection) is approximately 7 days earlier than in the uninfected control animals. The data for uninfected is consistent with previous studies on murine intestinal IgA ontogeny (see Discussion) (1, 62) . The relatively early development of a plateau may have been enhanced by the RRV infection, although that conclusion cannot be drawn from these data alone.
RRV-specific ASC. Figure 3a through d shows the mean (± standard error of the mean [SEMI) of total and rotavirusspecific ASC of each isotype, expressed as the number of ASC found per one million viable mononuclear cells derived from each of the four tissues studied at the specified time groups. The data from all time groups except day 10 postinfection are pooled in Table 2 , which shows the mean number of ASC (± SEM) of each isotype in the four tissues studied.
In our experiments, the RRV-specific IgA responses in LP were evident by 4 days postinfection, rose to peak around 30 days postinfection, and persisted at high levels for up to 63 days postinfection. As seen in Fig. 3a , at the height of the RRV-specific response, it accounted for more than 50% of all IgA-secreting cells. This confirms that a single dose of this heterologous virus is highly immunogenic in the mucosal immune system of mice.
A rise in RRV-specific IgA activity was also seen in the PP, which correlated with the response in LP but was much smaller in magnitude (Fig. 3b) . It is possible that this represented contamination of PP with LP cells, which was inevitable in spite of careful dissection. As expected, the spleen showed a predominance of IgM-and IgG-secreting cells, with little IgA activity. To be noted is the extremely small number of rotavirus-specific ASC of any isotype found in the spleen, a statistically significant difference from the small intestinal response. In the four experiments done at 4, 7, 8, and 11 days postinfection, significantly increased IgM and IgG responses was seen in the MLN (Fig. 3c) . These early IgG and IgM responses were not seen in any other tissue and disappeared by 14 days postinfection.
ELISA. Serum and intestinal contents obtained from naive controls and the mice sacrificed on day 4 postinfection showed IgA titers of <1,000 and <50 and IgG titers of <500 and <25, respectively. A fourfold or higher rise up to 64,000 and 3,200 for IgA and up to 32,000 and 1,600 for IgG, respectively, was noted in animals sacrificed after day 14, and the mean titers for the different groups are shown in Fig.  4 . The kinetics of the response are similar to those of the ASC by the ELISPOT technique. However, the peak serum IgG titer occurred at a later time, possibly reflecting the continued accumulation of IgG in the serum due to the long half-life of this immunoglobulin class.
When individual animals were compared, a fairly good correlation between serum and intestinal IgA titers was observed (r = 0.82). The correlation between the small intestinal and serum IgA titers may be related to the relatively efficient clearance of serum IgA by the hepatocytes into bile via a receptor-mediated pathway present in mice and some other rodents but not in humans (4, 57) . However, neither correlated with the number of ASC in the LP (r = 0.40 for RRV-specific serum IgA versus LP IgA ASC and 0.53 for intestinal contents), indicating other possible variables that influence antibody titer in these fluids.
Neutralization. Serum and intestinal content samples were collected at the time of lymphocyte harvest and assayed for RRV neutralization titers by immunohistochemical focus reduction assay. The results for samples from 12 experiments from 10 to 60 days postinfection are shown in Fig. 5 . While there is a suggestion of peaking titers 20 to 30 days all NS. Symbols: *, RRV-specific IgG; E, RRV-specific 1gM; El, RRV-specific IgA; 0, total IgG; A, total IgM; *, total IgA. postinfection, no statistical trend can be identified. Neutralizing antibody titers in nonimmunized animals and mothers prior to their litters being immunized were always <200 in serum and <20 in the intestinal contents. A representative group of dams tested at the same time as the immunized mice were sacrificed and showed significant neutralizing titers approaching those seen in the immunized litter (data not shown). Since the mice immunized were of suckling age, the mothers were housed in the same cage and were therefore exposed to the virus shed in the feces of immunized litter. Rotavirus-specific plasma cells in the small intestine starting at 10 days postinfection have previously been demonstrated by Dharakul et al. by using immunohistochemical methods in a murine model of homologous rotavirus infection (13) . Ninety-five percent of these specific cells were of the IgA isotype. We have come remarkably close to confirming this number by using a completely different technique and a heterologous rather than a homologous murine model. On the basis of data from Table 2 , we have shown that 89% of small intestine LP RRV-specific ASC were secreting IgA. This finding may not be surprising, however, as IgA-secreting cells of all specificities constitute 88% of ASC in this tissue (Table 1) .
Another important point of agreement between the present study and the data reported by Dharakul et al. is that approximately half of the cells bearing stainable immunoglobulins were virus specific in their study. This correlates well to our finding of almost 50% of ASC in the LP being virus specific at 20 to 60 days postinfection.
A similar predominance of local IgA response has also been demonstrated with other intestinal antigens such as the cholera toxoid, and a correlation with protection has been demonstrated (30, 58) . The local secretion of IgA is therefore now considered to be the important effector mechanism of mucosal immunity. It has been estimated that more than 40 mg/kg of body weight of IgA is secreted into the gut lumen daily, which is more than the total production of IgG, the°3 (0) were collected at the time cells were harvested for the ELISPOT assay, and immunochemical focus reduction neutralization assays were performed on MA104 cell monolayers. Titers indicated are the greatest dilutions of fluid that resulted in .50% reduction of virus-infected cells. All naive mice tested showed titers of <200 and <20 for serum and intestinal contents, respectively (data not shown). This was the lowest dilution tested. dominant immunoglobulin in serum (9) . The generation of these large amounts of secretory antibodies is dependent on the large number of IgA-producing cells in the LP, estimated to account for 70 to 80% of all immunoglobulin-producing cells in humans as well as mice (61, 62) . The ELISPOT technique developed for quantitating intestinal ASC in a precise and efficient manner now offers the means to study more effectively the response to rotavirus in this important organ of immunity. The detection of rotavirus-specific ASC in the LP as early as 4 days postinfection (compared with 10 days by immunohistochemical techniques) indicates the improved sensitivity of the ELISPOT in detection of smaller specific responses.
The overall sensitivity of this system for the identification of ASC in the small intestinal LP can be compared with results in published articles that reported the background production of immunoglobulin in the mouse small intestine as a function of age (62) . A rapid rise was seen in small intestinal IgA ASC beginning at 3 weeks of age and reaching a plateau of about 107 IgA ASC by 6 1 .5 x 107 per animal, which is virtually the same result. The fact that we observed total IgA levels at mature levels in mice by the time they were 3 weeks of age suggests that rotavirus infection hastened normal ontogeny. A single experiment on naive mice 14 days of age showed smaller number of IgA ASC in the LP compared with that in infected mice, but a larger number of uninfected controls at ages less than 3 to 4 weeks would be required to directly address this problem.
The incidence of surface and internal T-and B-cell markers in the lymphocyte populations of spleen and the different gut-associated lymphoid tissues of mice have been described and reviewed previously (6, 24, 33, 41, 42, 59, 60) . Though the ratio of T to B cells varies somewhat depending on the technique used, the reported differences between these tissues do not account for the marked differences we report in the number of ASC. The use of the total number of viable mononuclear cells as the denominator is a convention used by most authors studying the immune response in terms of ASC. This approach circumvents the discrepancies involved in identifying T and B cells by the use of different tests and attempting to distinguish immunoglobulin-containing plasma cells and membrane immunoglobulin-bearing B cells which may or may not be secreting antibodies. Moreover, since the total number of mononuclear cells in spleen and LP is known to be in the order of 108 per mouse and in the order of 107 in the PP and MLN, the relative contribution of each organ to the total body response can be appreciated (64) .
Although the location and isotype of the intestinal antibody response to rotavirus reported herein is similar to the responses to other intestinal antigens that have been previously described, the overall magnitude of the response to rotavirus is very strong compared with those to other antigens that have been studied with similar techniques. For instance, ASC specific for cholera toxin were quantitated in the LP by ELISPOT using petri dishes as the solid phase, and only 23 ASC per 106 mononuclear cells were found to be specific after a single oral dose of 10 pLg of cholera toxin, which could be enhanced to 700 ASC per 106 mononuclear cells after four boosters (32) . This was calculated as 7.8% of the total active ASC in this version of the ELISPOT assay, whereas the overall RRV-specific response in the LP in our study was 48%. Keyhole limpet hemocyanin, which alone does not stimulate a response when orally administered to mice, can be rendered antigenic if administered with cholera toxin. When the ELISPOT assay was used to quantitate this response, peak numbers of small intestinal LP lymphocytes of between 1,000 to 10,000 ASC per 106 mononuclear cells were noted, but no information regarding the total ASC present was available (69) .
The response to another orally administered (but nonreplicating) viral antigen, the formalin-inactivated influenza virus, was studied by using the ELISPOT technique (7). LP response was not studied, but the virus-specific ASC in PP cells were quantitated. The peak response was among PPderived IgA-secreting cells and was 27 ± 1.6 ASC per 106 mononuclear cells for virus alone and 326 + 1.5 ASC per 106 mononuclear cells when virus was administered with cholera toxin and after PP cells had been cultured in vitro for 2 days in the presence of viral antigen. These levels are markedly lower than we report for the same tissue and isotype (RRVspecific IgA ASC in PP = 2,600 ± 321) without either adjuvant or in vitro culture with antigen. These comparisons dramatically demonstrate the power of replicating rotavirus as a mucosal antigen. Though the other studies have used petri dishes as the solid phase (which, in our experience, may result in an underestimate of the total number of spots), the exponential differences in the small intestinal LP responses could not be attributed to such technical differences, especially considering that the responses in the other tissues are comparable.
The responses to rotavirus in the MLN and the spleen are more similar to that described for other antigens. When the response to the parasite Trichinella spiralis was quantitated in rat MLN, ASC were found to peak at 751 ± 298 IgA ASC per 106 mononuclear cells, with a peak at 12 days postinfection (65) (47, 66) .
The circulating and intestinal virus-specific immunoglobulins after a homologous infection in seronegative mice have been described by Sheridan et al. (53) . They demonstrated an early IgM response in serum, followed by the appearance of IgA and IgG in serum and a predominant IgA response in intestinal washings starting at day 7 and continuing to rise through their period of study (21 days). In our study, specific antibody titers for IgA and IgG in serum and IgG in feces continued to rise to 20 days postinfection and persisted at high levels, with some downward trend at 60 days postinfection (IgM titers were not studied). The peak serum IgG occurred at a later time, possibly reflecting the continued accumulation of IgG in the serum due to the longer half-life of this immunoglobulin class. This delayed peak of serum IgG has previously been described in studies of human volunteers (2) .
Mice are susceptible to rotavirus illness only between 1 to 13 days of age and are therefore generally considered unsuitable for use in studying the determinants of active disease protection. But Ward et al. have recently described the use of homologous murine rotaviruses (which cause epizootic diarrhea in infant mice) in adult mice with an end point of infection (viral shedding, but not diarrhea) which the authors proposed as a model for studies on rotavirus disease protection (68) . Adaptation of precise measures of antibody responses, such as the ELISPOT assay, may prove useful in attempts to determine the antibody correlates of disease protection.
The effects of virus dose and virus strain in this murine model of rotavirus infection have also been well studied. RRV has been shown to replicate in the intestinal epithelium and cause severe disease. However, only at very low doses of virus does replication occur to levels above the inoculated dose (43) . In this study, a relatively large dose of rotavirus was administered, approximately 1 log unit more than the dose needed to cause disease in 50% of the pups (35) , and infection therefore resulted in grossly evident diarrhea in more than 95% of the pups. This large dose results in the presence of considerable amounts of both replicating and nonreplicating antigen available in the intestine for presentation to the intestinal immune system. The relative contribution of each and relative importance of epithelial or the M-cell pathway taken by the replicating and nonreplicating antigen remain to be elucidated.
This model allows for the study of the local antibodysecreting cells and can be modified to study not only the virus-specific response but also protein-or epitope-specific responses. Recent developments in biotechnology have enhanced the enthusiasm for efforts at immunoprophylaxis by vaccination with synthetic viral peptides, bacterial and viral vectors, and reassortant strains. The effectiveness of these agents depends on the determination and optimization of their immunogenic properties. We believe that this model for studying local immune response will help realize the potential of these approaches.
